Navigation Links
Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
Date:1/9/2009

VANCOUVER, Jan. 9 /PRNewswire/ - Sirius Genomics, a developer of pharmacogenomic tests, announced today that it has signed a collaborative agreement with the United Kingdom Critical Care Genomics (UKCCG) Group. The agreement focuses on the continued development of Sirius' pharmacogenomic diagnostic for responsiveness to recombinant activated Protein C (sold by Eli Lilly and Company under the trademark Xigris(R)).

"The UKCCG group is conducting a large genomic association study looking at severe life-threatening infections and sepsis. This new collaboration with the UKCCG group will allow Sirius Genomics to significantly advance the development of our diagnostic by accessing the comprehensive database that the UKCCG group has compiled. We are delighted to be working with the UKCCG group to further our progress towards the commercialization of our first product," commented Dr. Brad Popovich, President and CEO of Sirius Genomics.

"The collaboration with Sirius Genomics is in direct alignment with our objective to disseminate and promote understanding of functional genomics in the wider intensive care community," stated Professor Charles Hinds, one of the Principal Investigators of the UKCCG Group. "We are very excited to be working with Sirius Genomics on this new collaboration."

Financial terms of the agreement were not disclosed.

About UKCCG: www.ukccg-gains.org/index.htm

The UKCCG Group is a collaborative consortium composed of multiple investigators, collaborators and members throughout the United Kingdom representing more than 35 hospitals. The group's primary objective is to undertake clinical functional genomics research in the critically ill and to develop related collaborative, laboratory based research projects with scientific colleagues.

About Sirius Genomics:
'/>"/>

SOURCE Sirius Genomics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
4. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
5. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
6. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
7. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
8. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
9. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
10. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...PRNewswire/ -- "Micro cap and small cap equities a...oker sponsorship and exposure as a ,buying window,...odity-driven stocks like gold, silver and other me...Group, Inc, Manhattan based investor relations fir...ties market in the US and Canada, and with expansi...
(Date:11/9/2009)... NexBio, Inc. announced the present...ege of Allergy, Asthma, and Immunology in Miami, F...udase®), a Sialidase, Decreases Airway Resist...nimal Models of Asthma". ,, DAS181 (Fludase ...rgeting drug candidate being studied in human clin...
(Date:11/8/2009)...lobal temperatures and energy costs continue to so...ustainable future. An attractive replacement for... online in Genome Research ( www.genome.org ), s...ioethanol-producing microorganisms, uncovering gen... technologies needed to implement production on a ...
(Date:11/6/2009)...ov. 6 Helix BioPharma Co...nnounced that John Docherty, president and chief o...Ford,s 6th annual Investor Summit on November 10, ...ity. Mr. Docherty will provide an overview of the...DOS47 and Topical Interferon Alpha-2b. The slide ...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
...b. 2 Secretropin(R) , the first clinically prove... is gaining the medical community,s acceptance as ... hormonal balance. Although classified as a natura...lable through a prescribing physician due to its c...n production and release of growth hormone. This...
...b. 2 Neuralstem, Inc. (NYSE Alternext US: CUR) an..., will present at the 11th Annual BIO CEO & In...9, at the Waldorf=Astoria Hotel, New York City. , ...61221/DCTH007LOGO ) , , Neuralstem,s presentation...0 a.m. Eastern Time. , , The presentation will be...
... Feb. 2 GeneGo, Inc., the leading systems biology...nsed MetaCore and entered a co marketing agreement...ll have GeneGo certified experts on staff to run t...l research community. QFAB will make MetaCore pat...s accessible to Australian and New Zealand academi...
Other Biology Technology:Secretropin(R) - Effective, Preferable, Affordable as an Alternative to Injectable Growth Hormone - Gains Momentum 2Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference 2Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region 2
(Date:11/9/2009)... and industry researchers has completed a first dr... project is an important first step in acceleratin...d addressing some of the many limitations that fac... a root crop that serves as the primary food sourc...ugh it has many properties that make it an importa...
(Date:11/9/2009)...le for the rapid, mysterious death of phytoplankto...llaborating scientists at Rutgers University and t...his same chemical may hold unexpected promise in c...ly unknown lipid, or fatty compound, in a virus th...yi , a phytoplankton that plays a major role in th...
(Date:11/8/2009)...he loss of a gene through deletion of genetic mate...nt abnormalities in learning and behavior, said a ... Medicine ( www.bcm.edu ) in a report that appears... "This research goes about 95 percent of the way ...ndividuals to this gene," said Dr. Arthur L. Beaud...
Breaking Biology News(10 mins):Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Developmental delay could stem from nicotinic receptor deletion 2Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 52800 1Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 52800 2Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 52800 3Radiation Plus Chemo a Good Option in Lung Cancer 52797 1Radiation Plus Chemo a Good Option in Lung Cancer 52797 2Colon capsule endoscopy diagnoses 64 percent of total polyps detected by conventional colonoscopy 52794 1Colon capsule endoscopy diagnoses 64 percent of total polyps detected by conventional colonoscopy 52794 2Colon capsule endoscopy diagnoses 64 percent of total polyps detected by conventional colonoscopy 52794 3Colon capsule endoscopy diagnoses 64 percent of total polyps detected by conventional colonoscopy 52794 4Colon capsule endoscopy diagnoses 64 percent of total polyps detected by conventional colonoscopy 52794 5
...suring a patient,s ratio of white blood cell types...n the similar conditions infectious mononucleosis ...atment decisions, according to an article in the J...mp; Neck Surgery, one of the JAMA/Archives journal...s) and infectious mononucleosis (caused by the Eps...
... 2003 epidemic of Highly Pathogenic Avian Influenz...demic of HPAI in the developed world. Gert-Jan Boe...is outbreak and produced a model which can predict...ther; the ,transmission kernel,. They also identif...arious control strategies, concluding that in thes...
...earchers have discovered that the genetic malfunct...d Noonan Syndrome (NS) produces an imbalance in th...embryonic brain. This imbalance, they theorize, co... to the neural pathology of the disorder. More bro...m underlying NS could apply to other inherited for...
Other Biology News:Common blood test can help distinguish between mononucleosis and tonsillitis 2How genetic malfunction causes a form of retardation 2
... array of accessories. JULABO water baths and sha...cted keypad offer a high operating comfort. The br...ature values is visible from across the lab. Advan... control eliminates temperature overshoot and prov...
SuperFreeze Peroxidase Conjugate Stabilizer from Pierce Biotechnology, Inc.
SA-HRP Dilution Buffer, 1L from Pierce Biotechnology, Inc.
...n optimized for the analysis of SearchLight® ...software to quickly and accurately locate and quan...or each section of a slide. SearchLight® Arra...ate standard ELISA analysis features, including cu...
Biology Products: